Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees
Outcome
OIG enforcement action against Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees for false claims. Penalty: $150 million.
Details
Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees — OIG Enforcement (2026)
OIG took enforcement action against Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees in 2026 involving false claims violations in the Independent Pharmacies sector.
Penalty: $150 million
Violation types: False Claims
Entity type: Pharmacy
Penalty type: Criminal
Source: Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works